The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Long-term Persistence of Zoster Vaccine Efficacy
Open accessAbstract
BACKGROUND: The Shingles Prevention Study (SPS) demonstrated zoster vaccine efficacy through 4 years postvaccination. A Short-Term Persistence Substudy (STPS) demonstrated persistence of vaccine efficacy for at least 5 years. A Long-Term Persistence Substudy (LTPS) was undertaken to further assess vaccine efficacy in SPS vaccine recipients followed for up to 11 years postvaccination. Study outcomes were assessed for the entire LTPS period and for each year from 7 to 11 years postvaccination. METHODS: Surveillance, case determination, and follow-up were comparable to those in SPS and STPS. Because SPS placebo recipients were offered zoster vaccine before the LTPS began, there were no unvaccinated controls. Instead, SPS and STPS placebo results were used to model reference placebo groups. RESULTS: The LTPS enrolled 6867 SPS vaccine recipients. Compared to SPS, estimated vaccine efficacy in LTPS decreased from 61.1% to 37.3% for the herpes zoster (HZ) burden of illness (BOI), from 66.5% to 35.4% for incidence of postherpetic neuralgia, and from 51.3% to 21.1% for incidence of HZ, and declined for all 3 outcome measures from 7 through 11 years postvaccination. Vaccine efficacy for the HZ BOI was significantly greater than zero through year 10 postvaccination, whereas vaccine efficacy for incidence of HZ was significantly greater than zero only through year 8. CONCLUSIONS: Estimates of vaccine efficacy decreased over time in the LTPS population compared with modeled control estimates. Statistically significant vaccine efficacy for HZ BOI persisted into year 10 postvaccination, whereas statistically significant vaccine efficacy for incidence of HZ persisted only through year 8.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citationThe Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Population-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Coplan, P. M., Schmader, K., Nikas, A., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., Bauer, M., Williams, H. M., Kaplan, K. M., et al. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2004.06.001 · Cited by 306
Self-citationJumaan, A. O., Yu, O., Jackson, L. A., Bohlke, K., Galil, K., & Seward, J. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/430325 · Cited by 285
Schmader, K. E., Oxman, M. N., Levin, M. J., Johnson, G., Zhang, J. H., Betts, R., Morrison, V. A., Gelb, L., Guatelli, J. C., Harbecke, R., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis638 · Cited by 230
Self-citationLeung, J., Harpaz, R., Molinari, N.-A., Jumaan, A., & Zhou, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq077 · Cited by 208
Vaccination against Herpes Zoster and Postherpetic Neuralgia
Oxman, M. N., Levin, M. J., & Shingles Prevention Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/522159 · Cited by 181
Self-citationIncidence of herpes zoster, 1997–2002
MULLOOLY, J. P., RIEDLINGER, K., CHUN, C., WEINMANN, S., & HOUSTON, H. (2005) · Epidemiology and Infection · doi:10.1017/s095026880400281x · Cited by 165
Schmader, K. E., Sloane, R., Pieper, C., Coplan, P. M., Nikas, A., Saddier, P., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., et al. (2007) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318065b6c9 · Cited by 163
Self-citation
Cited by
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Self-citationDooling, K. L., Guo, A., Patel, M., Lee, G. M., Moore, K., Belongia, E. A., & Harpaz, R. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6703a5 · Cited by 627
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 590
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Influence of immune aging on vaccine responses
Gustafson, C. E., Kim, C., Weyand, C. M., & Goronzy, J. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.017 · Cited by 286
Metadata
- Authors
- Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R., Gelb, L., Guatelli, J. C., Harbecke, R., Pachucki, C., Keay, S., Menzies, B., Griffin, M. R., Kauffman, C. A., Marques, A., Toney, J., Boardman, K., Su, S.-C., Li, X., Chan, I. S. F., Parrino, J., Annunziato, P., Oxman, M. N., for the Shingles Prevention Study Group, Davis, L., Kauffman, C., Keay, S., Straus, S., Marques, A., Soto, N., Brunell, P., Gnann, J., Serrao, R., Cotton, D., Goodman, R., Arbeit, R., Pachucki, C., Levin, M., Schmader, K., Keitel, W., Greenberg, R., Morrison, V., Wright, P., Griffin, M., Simberkoff, M., Yeh, S., Lobo, Z., Holodniy, M., Loutit, J., Betts, R., Gelb, L., Crawford, G., Guatelli, J., Brooks, P., Looney, D., Neuzil, K., Toney, J., Kauffman, C., Keay, S., Marques, A., Pachucki, C., Levin, M., Schmader, K., Morrison, V., Wright, P., Griffin, M., Betts, R., Gelb, L., Guatelli, J., Looney, D., Neuzil, K., Menzies, B., & Toney, J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-20
- Volume
- 60
- Issue
- 6
- Pages
- 900-909
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2125575192
- Cited by
- 296
- References
- 20
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Persistence of Zoster Vaccine Efficacy. https://app.cochat.ai/papers/10.1093/cid/ciu918
- The paper
- Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R., Gelb, L., Guatelli, J. C., Harbecke, R., Pachucki, C., Keay, S., Menzies, B., Griffin, M. R., Kauffman, C. A., Marques, A., Toney, J., Boardman, K., Su, S.-C., . . . Toney, J. (2015). Long-term Persistence of Zoster Vaccine Efficacy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu918
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.